Clinical Trial Update: Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma [NA]

View source ↗

Summary

This clinical trial investigating cerebrospinal fluid genetic testing to diagnose and monitor glioblastoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Glioblastoma | NA | Status: WITHDRAWN